Ghanima W, Lucas Boronat FJ, Carrai V, Rackwitz S. Sustained response off treatment after fostamatinib in refractory immune thrombocytopenia: A series of four case reports. Hematology. 2025 Dec;30(1):2456687. doi: 10.1080/16078454.2025.2456687.

Garabet L, Rangberg A, Eriksson AM, Jonassen CM, Teruel-Montoya R, Lozano ML, Martinez C, Pettersen HH, Mathisen ÅB, Tjønnfjord E, Tran H, Brodin E, Tsykunova G, Gebhart J, Bussel J, Ghanima W. MicroRNA-199a-5p may be a diagnostic biomarker of primary ITP. Br J Haematol. 2025 Jan 7. doi: 10.1111/bjh.19987.

Kuter DJ, Ghanima W. Evaluating rilzabrutinib in the treatment of immune thrombocytopenia. Immunotherapy. 2025 Aug 11:1-16. doi: 10.1080/1750743X.2025.2545170.

Tsykunova G, Holme PA, Tran HTT, Frederiksen H, Tjonnfjord E, Munthe LA, Drivet E, Kared H, Sørvoll IH, Ahlen MT, Mahevas M, Michel M, Bussel JB, Kuter DJ, Tvedt THA, Ghanima W. Safety and Efficacy of Daratumumab in Immune Thrombocytopenia. Blood Adv. 2025 Aug 5:bloodadvances.2025017279. doi: 10.1182/bloodadvances.2025017279.